The European Vascular and Endovascular Monitor (EVEM) is used to provide a measure of device usage across Europe and is especially good at revealing trends in the Vascular and Endovascular market.
We produce market reports in a quarterly format through the use of a panel of 250 centres across Western Europe.
Clients use the monitor to obtain key market, customer and sales information when they need it. Through an EVEM subscription clients can:
Abdominal aortic aneurysms (AAA)
- Monitors the endovascular device market dealing in treating abdominal aortic aneurysms
- Measure consumption/device usage and see accurate market share information for each leading brand.
- Track device average selling prices (ASPs) on a quarterly basis
Thoracic aortic aneurysms (TAA)
- Monitors the endovascular device market dealing in treating thoracic aortic aneurysms
- Measure consumption/device usage and see accurate market share information for each leading brand.
- Track device average selling prices (ASPs) on a quarterly basis
Reports
- AAA report Western Europe ,(in-depth quarterly and historical analysis)
- AAA European Executive Summary (compacted)
- TAA report Western Europe,(in-depth quarterly and historical analysis)
- TAA European Executive summary
- Executive Summary (quarterly overview)
- Database/Pivot table format
- Ad-hoc documents upon request
The EVEM methodology
The EVEM methodology consists of a consumption-based panel formed of Physicians from over 250 hospitals across Europe. All the hospitals are medium and high-volume centres. Data is received on a quarterly basis from Panel members and represents the whole hospital. Data is gathered through questionnaires specifically designed, through ongoing telephone interviews and 1-to-1 meetings at conferences.
Data from the Panel show changes in clinical practices and are a reliable indication of the most used technologies. However, in order to determine exact market share and turnover figures, our analysis model takes in account 11 other factors. These factors are (in alphabetical order):
- Brand reputation
- CE approval / National guidelines & protocols / reimbursement
- Corporate financial results
- Innovation
- Marketing campaigns
- Media impact
- Portfolio
- Pricing
- Product penetration rate
- Sales force
- Trends
The final data are cross-referenced with public registries and with sales figures from industry partners.The composition of our research Panel is stable: this allows us to appreciate changes in clinical practice, as well as in the use of technologies over a certain period of time. One-off questionnaires at meetings are used to validate the main findings from the report.
Market demographic coverage
The study examines every country in the European Union plus Norway and Switzerland. Data in most of the tables is segmented by market region, and these regions will be the following:
Germany
Italy
UK and Republic of Ireland
France
Nordic countries (Denmark, Sweden, Norway, Finland)
Belgium and Luxembourg
Netherlands
Spain
Portugal
Austria
Switzerland
Greece
